It is remarkable how the COVID-19 pandemic has ignited a new era in human immunology, prompting unprecedented efforts to study immune responses to diverse viruses worldwide. Observational cohorts of i...

Respiratory syncytial virus (RSV) contributes to substantial disease burden among older adults, particularly those with chronic heart and lung conditions.1 In the UK, the Joint Committee on Vaccinatio...

The ongoing pursuit of safe, effective, and accessible antiviral treatments for COVID-19 remains a key public health goal, even as the disease shifts into a milder, endemic stage for many. In this iss...